Parathyroid Hormone

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition

Volumn , Issue , 2013, Pages 208-214

  Nissenson, Robert A ^a   Jüppner, Harald ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

(1,25) vitamin D; Fibroblast growth; Parathyroid hormone (PTH); Phosphate excretion

Indexed keywords

EID: 85009929639     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118453926.ch26     Document Type: Chapter

References (59)

1. Potts JT. 2005. Parathyroid hormone: Past and present. J Endocrinol 187 (3): 311-25.
2. Zajac JD, Danks JA. 2008. The development of the parathyroid gland: From fish to human. Curr Opin Nephrol Hypertens 17 (4): 353-6.
3. Gordon J, Patel SR, Mishina Y, Manley NR. 2010. Evidence for an early role for BMP4 signaling in thymus and parathyroid morphogenesis. Dev Biol 339 (1): 141-54.
4. Adachi M, Tachibana K, Asakura Y, Tsuchiya T. 2006. A novel mutation in the GATA3 gene in a family with HDR syndrome (Hypoparathyroidism, sensorineural Deafness and Renal anomaly syndrome). J Pediatr Endocrinol Metab 19 (1): 87-92.
5. Grigorieva IV, Mirczuk S, Gaynor KU, Nesbit MA, Grigorieva EF, Wei Q, Ali A, Fairclough RJ, Stacey JM, Stechman MJ, Mihai R, Kurek D, Fraser WD, Hough T, Condie BG, Manley N, Grosveld F, Thakker RV. 2010. Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2. J Clin Invest 120 (6): 2144-55.
6. Ding C, Buckingham B, Levine MA. 2001. Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB. J Clin Invest 108 (8): 1215-20.
7. Mannstadt M, Bertrand G, Muresan M, Weryha G, Leheup B, Pulusani SR, Grandchamp B, Jüppner H, Silve C. 2008. Dominant-negative GCMB mutations cause an autosomal dominant form of hypoparathyroidism. J Clin Endocrinol Metab 93 (9): 3568-76.
8. Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M, Nissenson RA. 1987. Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest 80 (6): 1803-7.
9. Usdin TB, Hoare SR, Wang T, Mezey E, Kowalak JA. 1999. TIP39: A new neuropeptide and PTH2-receptor agonist from hypothalamus. Nat Neurosci 2 (11): 941-3.
10. Suva LJ, Winslow GA, Wettenhall RE, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY, et al. 1987. A parathyroid hormone-related protein implicated in malignant hypercalcemia: Cloning and expression. Science 237 (4817): 893-6.
11. Broadus AE, Mangin M, Ikeda K, Insogna KL, Weir EC, Burtis WJ, Stewart AF. 1988. Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormonelike peptide. N Engl J Med 319 (9): 556-63.
12. Gensure RC, Gardella TJ, Jüppner H. 2005. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors. Biochem Biophys Res Commun 328 (3): 666-78.
13. Kemper B, Habener JF, Mulligan RC, Potts JT Jr, Rich A. 1974. Pre-proparathyroid hormone: A direct translation product of parathyroid messenger RNA. Proc Natl Acad Sci U S A 71 (9): 3731-5.
14. Wiren KM, Ivashkiv L, Ma P, Freeman MW, Potts JT Jr, Kronenberg HM. 1989. Mutations in signal sequence cleavage domain of preproparathyroid hormone alter protein translocation, signal sequence cleavage, and membrane-binding properties. Mol Endocrinol 3 (2): 240-50.
15. Habener JF, Kemper B, Potts JT Jr. 1975. Calciumdependent intracellular degradation of parathyroid hormone: A possible mechanism for the regulation of hormone stores. Endocrinology 97 (2): 431-41.
16. D ' Amour P. 2006. Circulating PTH molecular forms: What we know and what we don ' t. Kidney Int Suppl (102): S29-33.
17. Murray TM, Rao LG, Divieti P, Bringhurst FR. 2005. Parathyroid hormone secretion and action: Evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocr Rev 26 (1): 78-113.
18. Brown EM. 1983. Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 56 (3): 572-81.
19. Brown EM, Gamba G, Riccardi D, Lombardi M, Butters R, Kifor O, Sun A, Hediger MA, Lytton J, Hebert SC. 1993. Cloning and characterization of an extracellular Ca(2 +)-sensing receptor from bovine parathyroid. Nature 366 (6455): 575-80.
20. Brown EM, MacLeod RJ. 2001. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81 (1): 239-97.
21. Chang W, Chen TH, Pratt S, Shoback D. 2000. Amino acids in the second and third intracellular loops of the parathyroid Ca2 +-sensing receptor mediate efficient coupling to phospholipase C. J Biol Chem 275 (26): 19955-63.
22. Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, Thakker RV. 1996. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335 (15): 1115-22.
23. Pollak MR, Seidman CE, Brown EM. 1996. Three inherited disorders of calcium sensing. Medicine (Baltimore) 75 (3): 115-23.
24. Ho C, Conner DA, Pollak MR, Ladd DJ, Kifor O, Warren HB, Brown EM, Seidman JG, Seidman CE. 1995. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11 (4): 389-94.
25. Wettschureck N, Lee E, Libutti SK, Offermanns S, Robey PG, Spiegel AM. 2007. Parathyroid-specific double knockout of Gq and G11 alpha-subunits leads to a phenotype resembling germline knockout of the extracellular Ca2 +-sensing receptor. Mol Endocrinol 21 (1): 274-80.
26. Egbuna OI, Brown EM. 2008. Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Pract Res Clin Rheumatol 22 (1): 129-48.
27. Hu J, Spiegel AM. 2007. Structure and function of the human calcium-sensing receptor: Insights from natural and engineered mutations and allosteric modulators. J Cell Mol Med 11 (5): 908-22.
28. Russell J, Sherwood LM. 1987. The effects of 1,25-dihydroxyvitamin D3 and high calcium on transcription of the pre-proparathyroid hormone gene are direct. Trans Assoc Am Physicians 100: 256-62.
29. Moallem E, Kilav R, Silver J, Naveh-Many T. 1998. RNA-Protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J Biol Chem 273 (9): 5253-9.
30. Ritter CS, Pande S, Krits I, Slatopolsky E, Brown AJ. 2008. Destabilization of parathyroid hormone mRNA by extracellular Ca2 + and the calcimimetic R-568 in parathyroid cells: Role of cytosolic Ca and requirement for gene transcription. J Mol Endocrinol 40 (1): 13-21.
31. Cozzolino M, Brancaccio D, Gallieni M, Galassi A, Slatopolsky E, Dusso A. 2005. Pathogenesis of parathyroid hyperplasia in renal failure. J Nephrol 18 (1): 5-8.
32. Chang W, Tu C, Chen TH, Bikle D, Shoback D. 2008. The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Sci Signal 1 (35): ra1.
33. Dvorak-Ewell MM, Chen TH, Liang N, Garvey C, Liu B, Tu C, Chang W, Bikle DD, Shoback DM. 2011. Osteoblast extracellular Ca(2 +)-sensing receptor regulates bone development, mineralization and turnover. J Bone Miner Res 26 (12): 2935-47.
34. Steddon SJ, Cunningham J. 2005. Calcimimetics and calcilytics-Fooling the calcium receptor. Lancet 365 (9478): 2237-9.
35. Silver J, Russell J, Sherwood LM. 1985. Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci U S A 82 (12): 4270-3.
36. Okazaki T, Igarashi T, Kronenberg HM. 1988l. 5 '-flanking region of the parathyroid hormone gene mediates negative regulation by 1,25-(OH)2 vitamin D3. J Biol Chem 263 (5): 2203-8.
37. Kim MS, Fujiki R, Murayama A, Kitagawa H, Yamaoka K, Yamamoto Y, Mihara M, Takeyama K, Kato S. 2007. 1Alpha,25(OH)2D3-induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter. Mol Endocrinol 21 (2): 334-42.
38. Naveh-Many T, Rahamimov R, Livni N, Silver J. 1995. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 96 (4): 1786-93.
39. Fukumoto S. 2008. Physiological regulation and disorders of phosphate metabolism-pivotal role of fibroblast growth factor 23. Intern Med 47 (5): 337-43.
40. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T. 2006. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444 (7120): 770-4.
41. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J. 2007. The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117 (12): 4003-8.
42. Krajisnik T, Bjorklund P, Marsell R, Ljunggren O, Akerström G, Jonsson KB, Westin G, Larsson TE. 2007. Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 195 (1): 125-31.
43. Jüppner H, Abou-Samra AB, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski LF Jr, Hock J, Potts JT Jr, Kronenberg HM, et al. 1991. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254 (5034): 1024-6.
44. Datta NS, Abou-Samra AB. 2009. PTH and PTHrP signaling in osteoblasts. Cell Signal 21 (8): 1245-54.
45. Weinstein LS, Liu J, Sakamoto A, Xie T, Chen M. 2004. Minireview: GNAS: Normal and abnormal functions. Endocrinology 145 (12): 5459-64.
46. Linglart A, Menguy C, Couvineau A, Auzan C, Gunes Y, Cancel M, Motte E, Pinto G, Chanson P, Bougneres P, Clauser E, Silve C. 2011. Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance. N Engl J Med 364 (23): 2218-26.
47. Fu Q, Manolagas SC, O ' Brien CA. 2006. Parathyroid hormone controls receptor activator of NF-kappaB ligand gene expression via a distant transcriptional enhancer. Mol Cell Biol 26 (17): 6453-68.
48. Keller H, Kneissel M. 2005. SOST is a target gene for PTH in bone. Bone 37 (2): 148-58.
49. Pfister MF, Forgo J, Ziegler U, Biber J, Murer H. 1999. cAMP-dependent and-independent downregulation of type II Na-Pi cotransporters by PTH. Am J Physiol 276 (5 Pt 2): F720-5.
50. Guo J, Liu M, Yang D, Bouxsein ML, Thomas CC, Schipani E, Bringhurst FR, Kronenberg HM. 2010. Phospholipase C signaling via the parathyroid hormone (PTH)/PTH-related peptide receptor is essential for normal bone responses to PTH. Endocrinology 151 (8): 3502-13.
51. Vilardaga JP, Frank M, Krasel C, Dees C, Nissenson RA, Lohse MJ. 2001. Differential conformational requirements for activation of G proteins and the regulatory proteins arrestin and G protein-coupled receptor kinase in the G protein-coupled receptor for parathyroid hormone (PTH)/PTH-related protein. J Biol Chem 276 (36): 33435-43.
52. Bisello A, Manen D, Pierroz DD, Usdin TB, Rizzoli R, Ferrari SL. 2004. Agonist-specific regulation of parathyroid hormone (PTH) receptor type 2 activity: Structural and functional analysis of PTH-and tuberoinfundibular peptide (TIP) 39-stimulated desensitization and internalization. Mol Endocrinol 18 (6): 1486-98.
53. Bianchi EN, Ferrari SL. 2009. Beta-arrestin2 regulates parathyroid hormone effects on a p38 MAPK and NFkappaB gene expression network in osteoblasts. Bone 45 (4): 716-25.
54. Gesty-Palmer D, Flannery P, Yuan L, Corsino L, Spurney R, Lefkowitz RJ, Luttrell LM. 2009. A beta-arrestinbiased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci Transl Med 1 (1): 1ra.
55. Ferrandon S, Feinstein TN, Castro M, Wang B, Bouley R, Potts JT, Gardella TJ, Vilardaga JP. 2009. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat Chem Biol 5 (10): 734-42.
56. Wan M, Yang C, Li J, Wu X, Yuan H, Ma H, He X, Nie S, Chang C, Cao X. 2008. Parathyroid hormone signaling through low-density lipoprotein-related protein 6. Genes Dev 22 (21): 2968-79.
57. Romero G, Sneddon WB, Yang Y, Wheeler D, Blair HC, Friedman PA. 2010. Parathyroid hormone receptor directly interacts with dishevelled to regulate beta-Catenin signaling and osteoclastogenesis. J Biol Chem 285 (19): 14756-63.
58. Gensure RC, Ponugoti B, Gunes Y, Papasani MR, Lanske B, Bastepe M, Rubin DA, Jüppner H. 2004. Identification and characterization of two parathyroid hormone-like molecules in zebrafish. Endocrinology 145 (4): 1634-9.
59. John MR, Arai M, Rubin DA, Jonsson KB, Jüppner H. 2002. Identification and characterization of the murine and human gene encoding the tuberoinfundibular peptide of 39 residues. Endocrinology 143 (3): 1047-57.